Aspen Pharmacare
Aspen Pharmacare, a leading global pharmaceutical company headquartered in South Africa (ZA), has established itself as a key player in the healthcare industry since its founding in 1850. With a strong presence in over 50 countries, Aspen operates primarily in the areas of generic and branded pharmaceuticals, as well as consumer healthcare products. The company is renowned for its diverse portfolio, which includes anaesthetics, thrombosis, and oncology medications, setting it apart through a commitment to quality and innovation. Aspen's strategic acquisitions and partnerships have bolstered its market position, making it one of the largest pharmaceutical manufacturers in Africa. Notable achievements include its rapid expansion into international markets and a focus on sustainable healthcare solutions, reinforcing its reputation as a trusted provider in the global pharmaceutical landscape.
DitchCarbon Score
How does Aspen Pharmacare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aspen Pharmacare's score of 49 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Aspen Pharmacare's reported carbon emissions
In 2023, Aspen Pharmacare reported total carbon emissions of approximately 149,301,000 kg CO2e, comprising 37,000,000 kg CO2e from Scope 1, 112,000,000 kg CO2e from Scope 2, and 70,991,000 kg CO2e from Scope 3 emissions. The company has set ambitious climate commitments, aiming to reduce global carbon dioxide emissions by 45% by 2030 compared to 2010 levels, with a long-term goal of achieving net zero emissions by around mid-century. This commitment encompasses all scopes of emissions, reflecting a comprehensive approach to sustainability. Aspen's proactive stance on climate action positions it as a responsible leader in the pharmaceutical industry, aligning with global efforts to combat climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 10,917,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 114,615,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | 00,000,000 | - | - | - | 00,000,000 | 00,000,000 | - | - | 00,000,000 | 000,000 | 00,000,000 | - | 00,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aspen Pharmacare is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
